Zobrazeno 1 - 10
of 16
pro vyhledávání: '"John N. Bickers"'
Autor:
Kenneth J. Kopecky, Michael R. Grever, John N. Bickers, Laura Kingsbury, Frederick R. Appelbaum, Stanley P. Balcerzak, Sheryl R. Simon, James K. Weick, Jeanna L Welborn, David R. Head, H. E. Hynes
Publikováno v:
Blood. 88:2841-2851
Interest in high-dose cytarabine (HDAC) for both induction and postremission therapy for acute myeloid leukemia (AML) prompted the Southwest Oncology Group (SWOG) to initiate a randomized trial comparing HDAC with standard-dose cytarabine (SDAC) for
Autor:
Thomas A. Hosty, Henry E. Wilson, Lizardo Cerezo, Charles A. Coltman, Catherine M. Craven, Richard A. Savage, John H. Saiki, Francis S. Morrison, David R. Head, Robert J. Hartsock, John J. Hutton, John N. Bickers
Publikováno v:
American Journal of Hematology. 18:47-57
After initial French-American-British (FAB) diagnosis by a multiinstitutional Southwest Oncology Group panel, slides of acute leukemia cases were recirculated to panel members for second review. The reproducibility of the FAB classification is analyz
Autor:
Christopher F. Bryan, John N. Bickers, John Rainey, Mary Z. Pelias, Robert C. Elston, Stephen H. Leech
Publikováno v:
Cancer. 51:1408-1411
Human leukocyte antigens (HLA) were identified in 22 black Americans with multiple myeloma. No significant association was observed between antigens at either the A or the B locus. At the C locus, in contrast, HLA-Cw5 was more prevalent in the patien
Autor:
Kenneth B. McCredie, Olga J. Pendleton, John N. Bickers, James S. Hewlett, Emil J. Freireich, Charles A. Coltman, Gerald P. Bodey
Publikováno v:
Medical and Pediatric Oncology. 10:173-183
Four Southwest Oncology Group clinical trials in adult acute leukemia were conducted between June 1967 and January 1975 involving 741 adult patients. The trials involved Cytarabine (ARA-C) alone and in combination. The last patient started treatment
Autor:
John N. Bickers, Robert L. Palmer, John H. Costanzi, B. Hoogstraten, Henry E. Wilson, N. Gad El Mawli, Clarence B. Vaughn, L. Heilburn, Tranum Bl, T. R. Maloney, Tate Thigpen, B. McDonald, S. Rasmusen
Publikováno v:
Cancer. 49:835-839
The Southwest Oncology Group tested three combinations of drugs with Adriamycin to identify a best regimen for treatment of advanced breast cancer. Adriamycin, cyclophosphamide, and 5-fluorouracil (5FU)(FAC); Adriamycin and cyclosphosphamide (AC); an
Autor:
Richard J Reed, W. J. Stuckey, John N. Bickers, Robert B. Livingston, Joel White, Ronald L. Stephens, Lance K. Heilbrun, Joseph H. Saiers, Joseph D. McCcracken, Michael K. Samson
Publikováno v:
Cancer. 46:2335-2340
From November 1976 to November 1978, the Southwest Oncology Group treated 254 patients with extensive (metastatic) small cell carcinoma of the lung with combination chemotherapy and radiotherapy with and without BCG immunotherapy. Patients receiving
Autor:
Thomas A. Hosty, John J. Hutton, John H. Saiki, Catherine M. Craven, David R. Head, Henry E. Wilson, Richard A. Savage, Robert J. Hartsock, Francis S. Morrison, John N. Bickers, Lizardo Cerezo, Charles A. Coltman
Publikováno v:
Cancer. 55:1979-1986
Institutional performance in application of the French-American-British (FAB) classification of acute leukemia in The Southwest Oncology Group is presented, demonstrating a disparity between institutional and expert performance. A significant improve
Autor:
W. J. Stuckey, Emil J. Freireich, James S. Hewlett, Edmund A. Gehan, Henry E. Wilson, E. J. Van Slyck, John N. Bickers, Charles A. Coltman
Publikováno v:
Archives of Internal Medicine. 133:251-259
Publikováno v:
Blood. 19:304-312
A patient is reported with pyridoxine responsive anemia superimposed upon a chronic hypochromic anemia with excess iron storage. A specific response to pyridoxine was demonstrated on several occasions with restoration of the blood picture to its orig